Hatched in the Queen’s Innovation Centre Summer Initiative Program (QICSI) in the Summer of 2017, Spectra Plasmonics has developed a hand-held method of giving Supervised Consumption sites, first responders and law enforcement officers a proven way to instantly detect deadly amounts of fentanyl, carfentanil and other harmful components that have been added to more common street drugs like heroin and cocaine.
Fentanyl is around 50 to 100 times more toxic than morphine. Carfentanil is approximately 10,000 times more toxic than morphine, making it deadly in extremely small amounts. But it can now easily be detected with Spectra Plasmonics innovation.
With the Spectra Plasmonics solution, on-site results take minutes versus months of wait-time from overrun labs. At a safe injection site, this means a person can pre-test drugs for deadly substances before safely injecting them. To read the full story and learn about how Launch Lab has worked with Spectra Plasmonics, please click here.